@article{5f976bcfce414fc6bbe30ed047aad59c,
title = "Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice",
keywords = "alpha interferon, bosutinib, dasatinib, imatinib, nilotinib, ponatinib, protein tyrosine kinase inhibitor, adult, Article, cancer chemotherapy, cancer patient, chronic myeloid leukemia, chronopharmacology, clinical practice, drug intoxication, drug safety, drug withdrawal, feasibility study, female, follow up, human, Italian (citizen), leukemia relapse, leukemia remission, major clinical study, male, observational study, oncologist, pregnancy, retreatment, retrospective study, shared decision making, treatment duration, treatment failure, treatment response, treatment withdrawal",
author = "C. Fava and G. Rege-Cambrin and I. Dogliotti and M. Cerrano and P. Berchialla and M. Dragani and G. Rosti and F. Castagnetti and G. Gugliotta and B. Martino and C. Gambacorti-Passerini and E. Abruzzese and C. Elena and P. Pregno and A. Gozzini and I. Capodanno and M. Bergamaschi and M. Crugnola and M. Bocchia and S. Galimberti and D. Rapezzi and A. Iurlo and D. Cattaneo and R. Latagliata and M. Breccia and M. Cedrone and M. Santoro and M. Annunziata and L. Levato and F. Stagno and F. Cavazzini and N. Sgherza and V. Giai and L. Luciano and S. Russo and P. Musto and G. Caocci and F. Sor{\`a} and F. Iuliano and F. Lunghi and G. Specchia and F. Pane and D. Ferrero and M. Baccarani and G. Saglio",
note = "Export Date: 12 November 2019 CODEN: HAEMA Correspondence Address: Fava, C.; Department of Clinical and Biological Sciences, University of TurinItaly; email: carmen.fava@unito.it",
year = "2019",
doi = "10.3324/haematol.2018.205054",
language = "English",
volume = "104",
pages = "1589--1596",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "8",
}